Cited by 3,162Lipoproteins and Cardiovascular HealthCardiovascular Health and Risk FactorsDiabetes, Cardiovascular Risks, and Lipoproteins

The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.

High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies.

Open access

Gordon, D J, Probstfield, J L, Garrison, R J, Neaton, J D, Castelli, W P, Knoke, J D, Jacobs, D R, Bangdiwala, S, Tyroler, H A·1989·Circulation

DOI 10.1161/01.cir.79.1.8

Open this paper in CoChat — free account Open PDF

Abstract

The British Regional Heart Study (BRHS) reported in 1986 that much of the inverse relation of high-density lipoprotein cholesterol (HDLC) and incidence of coronary heart disease was eliminated by covariance adjustment. Using the proportional hazards model and adjusting for age, blood pressure, smoking, body mass index, and low-density lipoprotein cholesterol, we analyzed this relation separately in the Framingham Heart Study (FHS), Lipid Research Clinics Prevalence Mortality Follow-up Study (LRCF) and Coronary Primary Prevention Trial (CPPT), and Multiple Risk Factor Intervention Trial (MRFIT). In CPPT and MRFIT (both randomized trials in middle-age high-risk men), only the control groups were analyzed. A 1-mg/dl (0.026 mM) increment in HDLC was associated with a significant coronary heart disease risk decrement of 2% in men (FHS, CPPT, and MRFIT) and 3% in women (FHS). In LRCF, where only fatal outcomes were documented, a 1-mg/dl increment in HDLC was associated with significant 3.7% (men) and 4.7% (women) decrements in cardiovascular disease mortality rates. The 95% confidence intervals for these decrements in coronary heart and cardiovascular disease risk in the four studies overlapped considerably, and all contained the range 1.9-2.9%. HDLC levels were essentially unrelated to non-cardiovascular disease mortality. When differences in analytic methodology were eliminated, a consistent inverse relation of HDLC levels and coronary heart disease event rates was apparent in BRHS as well as in the four American studies.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1161/01.cir.79.1.8

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge
Friedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972) · Clinical Chemistry · doi:10.1093/clinchem/18.6.499 · Cited by 32,423
Regression Models and Life-Tables
Cox, D. R. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_37 · Cited by 26,297
High density lipoprotein as a protective factor against coronary heart disease
Gordon, T., Castelli, W. P., Hjortland, M. C., Kannel, W. B., & Dawber, T. R. (1977) · The American Journal of Medicine · doi:10.1016/0002-9343(77)90874-9 · Cited by 5,059
Self-citation
Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with Dyslipidemia
Frick, M. H., Elo, O., Haapa, K., Heinonen, O. P., Heinsalmi, P., Helo, P., Huttunen, J. K., Kaitaniemi, P., Koskinen, P., Manninen, V., et al. (1987) · New England Journal of Medicine · doi:10.1056/nejm198711123172001 · Cited by 3,881
A SIMPLIFIED METHOD FOR THE ESTIMATION OF TOTAL CHOLESTEROL IN SERUM AND DEMONSTRATION OF ITS SPECIFICITY
Abell, L. L., Levy, B. B., Brodie, B. B., & Kendall, F. E. (1952) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)50907-3 · Cited by 3,085
Incidence of Coronary Heart Disease and Lipoprotein Cholesterol Levels
Castelli, W. P. (1986) · JAMA · doi:10.1001/jama.256.20.2835 · Cited by 2,512
Self-citation
Epidemiological approaches to heart disease: the Framingham study
Dawber, T. R., Meadors, G. F., & Moore, F. E. (1951) · American Journal of Public Health and the Nations Health · doi:10.2105/ajph.41.3.279 · Cited by 2,148
Beneficial Effects of Combined Colestipol-Niacin Therapy on Coronary Atherosclerosis and Coronary Venous Bypass Grafts
Blankenhorn, D. H. (1987) · JAMA · doi:10.1001/jama.1987.03390230069027 · Cited by 1,654
High density lipoprotein metabolism.
Eisenberg, S. (1984) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37713-0 · Cited by 1,212

Flagged first, then by citations

Show all 27 references

Research works printed but not linked: 8

Miller NE, Forde OH, Thelle DS, Mjos OD: The Tromso Heart Study: High-density lipoprotein and coronary heart disease: A prospective case-control study. Lancet 1977; 1:965-970
Gordon DJ, Knoke J, Probstfield JL, Superko R, Tyroler HA (for the Lipid Research Clinics Program): High-density lipoprotein cholesterol and coronary heart disease in hyper- cholesterolemic men: The Lipid Research Clinics Coronary Primary Prevention Trial. Circulation 1986;74:1217-1225
The Lipid Research Clinics Program Epidemiology Commit- tee: Plasma Lipid Distribution in Selected North American Populations: The Lipid Research Clinics Program Preva- lence Study. Circulation 1979;60:427-439
The Lipid Research Clinics Program: The Coronary Primary Prevention Trial: Design and implementation. J Chronic Dis 1979;32:609-631
The Lipid Research Clinics Program: The Lipid Research Clinics Coronary Primary Prevention Trial Results: I. Reduc- tion in incidence of coronary heart disease. JA1M 1984; 251:351-364
The Multiple Risk Factor Intervention Trial Group: Statisti- cal design considerations in the NHLBI Multiple Risk Fac- tor Intervention Trial (MRFIT). J Chronic Dis 1977; 30:261-275
Multiple Risk Factor Intervention Trial Research Group: Multiple Risk Factor Intervention Trial: Risk factor changes and mortality results. JAMA 1982;248:1465-1477
Shestov DB: Results of four years of follow-up of USSR populations, in USA-USSR First Lipoprotein Symposium. US Department of Health and Human Services Publication (NIH) 83-1966, Bethesda, Md, 1982, pp 391-407

Sorted by citations

Items 601–700 of 1,007

High-density Lipoprotein Cholesterol Is Negatively Correlated with Bone Mineral Density and Has Potential Predictive Value for Bone Loss
Tang, Y., Wang, S., Yi, Q., Xia, Y., & Geng, B. (2021) · Lipids in Health and Disease · doi:10.1186/s12944-021-01497-7 · Cited by 71
Cholesteryl Ester Transfer Protein Inhibition Reduces Major Adverse Cardiovascular Events by Lowering Apolipoprotein B Levels
Nelson, A. J., Sniderman, A. D., Ditmarsch, M., Dicklin, M. R., Nicholls, S. J., Davidson, M. H., & Kastelein, J. J. P. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23169417 · Cited by 72
Postprandial lipemia: An under-recognized atherogenic factor in patients with diabetes mellitus
Pastromas, S. C., Terzi, A. B., Tousoulis, D., & Koulouris, S. N. (2007) · International Journal of Cardiology · doi:10.1016/j.ijcard.2007.04.172 · Cited by 70
Serum lipid concentrations among persons with spinal cord injury – A systematic review and meta-analysis of the literature
Gilbert, O. N., Croffoot, J. R., Taylor, A. J., Nash, M. S., Schomer, K. G., & Groah, S. L. (2013) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.11.028 · Cited by 69
Systemic manifestations of periodontitis in the non‐human primate
Ebersole, J. L., Cappelli, D. P., Mott, G. E., Kesavalu, L. N., Holt, S. C., & Singer, R. E. (1999) · Journal of Periodontal Research · doi:10.1111/j.1600-0765.1999.tb02266.x · Cited by 69
Training and Detraining Effects of a Combined-strength and Aerobic Exercise Program on Blood Lipids in Patients With Coronary Artery Disease
Tokmakidis, S. P., & Volaklis, K. A. (2003) · Journal of Cardiopulmonary Rehabilitation · doi:10.1097/00008483-200305000-00006 · Cited by 69
Dietary supplementation with d-tagatose in subjects with type 2 diabetes leads to weight loss and raises high-density lipoprotein cholesterol
Donner, T. W., Magder, L. S., & Zarbalian, K. (2010) · Nutrition Research · doi:10.1016/j.nutres.2010.09.007 · Cited by 69
Evaluating the Incremental Benefits of Raising High-Density Lipoprotein Cholesterol Levels During Lipid Therapy After Adjustment for the Reductions in Other Blood Lipid Levels
Grover, S. A., Kaouache, M., Joseph, L., Barter, P. J., & Davignon, J. (2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2009.328 · Cited by 69
New Perspectives on the Management of Low Levels of High-Density Lipoprotein Cholesterol
Harper, C. R., & Jacobson, T. A. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.10.1049 · Cited by 68
Postmenopausal hormone therapy and atherosclerotic disease
Manson, J. E. (1994) · American Heart Journal · doi:10.1016/0002-8703(94)90257-7 · Cited by 69
Obicetrapib: Reversing the Tide of CETP Inhibitor Disappointments
Kastelein, J. J. P., Hsieh, A., Dicklin, M. R., Ditmarsch, M., & Davidson, M. H. (2023) · Current Atherosclerosis Reports · doi:10.1007/s11883-023-01184-1 · Cited by 69
Prevalence of Low High-Density Lipoprotein Cholesterol in Patients With Documented Coronary Heart Disease or Risk Equivalent and Controlled Low-Density Lipoprotein Cholesterol
Alsheikh-Ali, A. A. A., Lin, J.-L., Abourjaily, P. N., Ahearn, D., Kuvin, J. T., & Karas, R. H. (2007) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2007.06.058 · Cited by 69
A Cholesterol Biosensor Based on the NIR Electrogenerated-Chemiluminescence (ECL) of Water-Soluble CdSeTe/ZnS Quantum Dots
Stewart, A. J., O’Reilly, E. J., Moriarty, R. D., Bertoncello, P., Keyes, T. E., Forster, R. J., & Dennany, L. (2015) · Electrochimica Acta · doi:10.1016/j.electacta.2015.01.073 · Cited by 68
ABCA1 mutation carriers with low high-density lipoprotein cholesterol are characterized by a larger atherosclerotic burden
Bochem, A. E., van Wijk, D. F., Holleboom, A. G., Duivenvoorden, R., Motazacker, M. M., Dallinga‐Thie, G. M., de Groot, E., Kastelein, J. J. P., Nederveen, A. J., Hovingh, G. K., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs376 · Cited by 70
Molecules That Mimic Apolipoprotein A-I: Potential Agents for Treating Atherosclerosis
Leman, L. J., Maryanoff, B. E., & Ghadiri, M. R. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm4005847 · Cited by 69
Role of lipid and lipoprotein profiles in risk assessment and therapy
Ballantyne, C. M., & Hoogeveen, R. C. (2003) · American Heart Journal · doi:10.1016/s0002-8703(02)94701-0 · Cited by 68
High Density Lipoproteins (HDL) and the Oxidative Hypothesis of Atherosclerosis
Bonnefont‐Rousselot, D., Thérond, P., Beaudeux, J., Peynet, J., Legrand, A., & Delattre, J. (1999) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.1999.139 · Cited by 68
Relation of fasting plasma insulin concentration to high density lipoprotein cholesterol and triglyceride concentrations in men.
Laws, A., King, A. C., Haskell, W. L., & Reaven, G. M. (1991) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.11.6.1636 · Cited by 68
Emerging therapies for raising high-density lipoprotein cholesterol (HDL-C) and augmenting HDL particle functionality
Barylski, M., Toth, P. P., Nikolic, D., Banach, M., Rizzo, M., & Montalto, G. (2014) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2013.11.001 · Cited by 67
Nonstatin Therapies for Management of Dyslipidemia: A Review
Sando, K. R., & Knight, M. (2015) · Clinical Therapeutics · doi:10.1016/j.clinthera.2015.09.001 · Cited by 69
Gut Microbiota-Associated Activation of TLR5 Induces Apolipoprotein A1 Production in the Liver
Yiu, J. H. C., Chan, K.-S., Cheung, J., Li, J., Liu, Y., Wang, Y., Fung, W. W. L., Cai, J., Cheung, S. W. M., Dorweiler, B., et al. (2020) · Circulation Research · doi:10.1161/circresaha.120.317362 · Cited by 67
Special Turku Coronary Risk Factor Intervention Project for Babies (STRIP)
Simell, O., Niinikoski, H., Rönnemaa, T., Lapinleimu, H., Routi, T., Lagström, H., Salo, P., Jokinen, E. V., & Viikari, J. S. A. (2000) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/72.5.1316s · Cited by 67
Effects of Diet on High-Density Lipoprotein Cholesterol
Siri‐Tarino, P. W. (2011) · Current Atherosclerosis Reports · doi:10.1007/s11883-011-0207-y · Cited by 70
Should low high-density lipoprotein cholesterol (HDL-C) be treated?
Toth, P. P., Barylski, M., Nikolić, D., Rizzo, M., Montalto, G., & Banach, M. (2013) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2013.11.002 · Cited by 67
Ligustrazine improves atherosclerosis in rat via attenuation of oxidative stress
Fengrong, J., Qian, J., Chen, S., Zhang, W., & Liu, C. (2011) · Pharmaceutical Biology · doi:10.3109/13880209.2010.551776 · Cited by 67
High-Density Lipoprotein at the Interface of Type 2 Diabetes Mellitus And Cardiovascular Disorders
Linthout, S. V., Spillmann, F., Schultheiss, H., & Tschöpe, C. (2010) · Current Pharmaceutical Design · doi:10.2174/138161210791051031 · Cited by 67
A lifestyle program for treated hypertensives improved health-related behaviors and cardiovascular risk factors, a randomized controlled trial
Burke, V., Beilin, L. J., Christian, H. E., Mansour, J., Williams, A., & Mori, T. A. (2006) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2006.05.012 · Cited by 69
The Therapeutic Role of Niacin in Dyslipidemia Management
Boden, W. E., Sidhu, M. S., & Toth, P. P. (2013) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248413514481 · Cited by 69
High-density lipoprotein inhibits migration of vascular smooth muscle cells through its sphingosine 1-phosphate component
Tamama, K., Tomura, H., Sato, K., Malchinkhuu, E., Damirin, A., Kimura, T., Kuwabara, A., Murakami, M., & Okajima, F. (2004) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2004.07.032 · Cited by 67
Rice Intake Is Associated with Reduced Risk of Mortality from Cardiovascular Disease in Japanese Men but Not Women1–3
Eshak, E. S., Iso, H., Date, C., Yamagishi, K., Kikuchi, S., Watanabe, Y., Wada, Y., & Tamakoshi, A. (2011) · Journal of Nutrition · doi:10.3945/jn.110.132167 · Cited by 66
Unravelling HDL—Looking beyond the Cholesterol Surface to the Quality Within
Kajani, S., Curley, S., & McGillicuddy, F. C. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19071971 · Cited by 70
Lipid Responses to a Dietary Docosahexaenoic Acid Supplement in Men and Women with Below Average Levels of High Density Lipoprotein Cholesterol
Maki, K. C., Elswyk, M. E. V., McCarthy, D., Hess, S. P., Veith, P. E., Bell, M., Subbaiah, P. V., & Davidson, M. H. (2005) · Journal of the American College of Nutrition · doi:10.1080/07315724.2005.10719465 · Cited by 66
Men and Women Differ in Lipoprotein Response to Dietary Saturated Fat and Cholesterol Restriction
Li, Z., Lamon‐Fava, S., Velez‐Carrasco, W., Lichtenstein, A. H., McNamara, J. R., Ordovás, J. M., Schaefer, E. J., & Otvos, J. D. (2003) · Journal of Nutrition · doi:10.1093/jn/133.11.3428 · Cited by 67
Sex differences in lipoprotein metabolism and dietary response: Basis in hormonal differences and implications for cardiovascular disease
Knopp, R. H., Paramsothy, P., Retzlaff, B. M., Fish, B. E., Walden, C. E., Dowdy, A. A., Tsunehara, C. H., Aikawa, K., & Cheung, M. C. (2006) · Current Cardiology Reports · doi:10.1007/s11886-006-0104-0 · Cited by 67
Dietary Restriction of Saturated Fat and Cholesterol Decreases HDL ApoA-I Secretion
Velez‐Carrasco, W., Lichtenstein, A. H., Welty, F. K., Li, Z., Lamon‐Fava, S., Dolnikowski, G. G., & Schaefer, E. J. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.4.918 · Cited by 67
A Major Locus Influencing Plasma High-Density Lipoprotein Cholesterol Levels in the San Antonio Family Heart Study
Mahaney, M. C., Blangero, J., Rainwater, D. L., Comuzzie, A. G., VandeBerg, J. L., D, M. P. S. M., MacCluer, J. W., & Hixson, J. E. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.10.1730 · Cited by 67
Influence of enhanced bioavailable curcumin on obesity-associated cardiovascular disease risk factors and arterial function: A double-blinded, randomized, controlled trial
Campbell, M. S., Ouyang, A., Krishnakumar, I. M., Charnigo, R. J., Westgate, P. M., & Fleenor, B. S. (2019) · Nutrition · doi:10.1016/j.nut.2019.01.002 · Cited by 66
Dietary guidelines for saturated fatty acids are not supported by the evidence
Parodi, P. W. (2015) · International Dairy Journal · doi:10.1016/j.idairyj.2015.08.007 · Cited by 69
Hypolipidemic and Antioxidative Effects of the Plant Glycoprotein (36 kDa) fromRhus vernicifluaStokes Fruit in Triton WR-1339-Induced Hyperlipidemic Mice
Oh, P., Lee, S., & Lim, K. (2006) · Bioscience Biotechnology and Biochemistry · doi:10.1271/bbb.70.447 · Cited by 66
Butter increased total and LDL cholesterol compared with olive oil but resulted in higher HDL cholesterol compared with a habitual diet
Engel, S., & Tholstrup, T. (2015) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.115.112227 · Cited by 71
Risk Factors and the Sex Differential in Coronary Artery Disease
Price, J. F., & Fowkes, F. G. R. (1997) · Epidemiology · doi:10.1097/00001648-199709000-00018 · Cited by 66
A new method for HDL particle sizing by polyacrylamide gradient gel electrophoresis using whole plasma
Pérusse, M., Pascot, A., Després, J., Couillard, C., & Lamarche, B. (2001) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)31585-6 · Cited by 66
Effects of Chromium Supplementation on Serum High-Density Lipoprotein Cholesterol Levels in Men Taking Beta-Blockers
Roeback, J. R., Hla, K. M., Chambless, L. E., & Fletcher, R. H. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-12-917 · Cited by 66
Cardiovascular Disease in Women
Stock, E. O., & Redberg, R. (2012) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2012.07.001 · Cited by 65
High intake of regular-fat cheese compared with reduced-fat cheese does not affect LDL cholesterol or risk markers of the metabolic syndrome: a randomized controlled trial
Raziani, F., Tholstrup, T., Kristensen, M. D., Svanegaard, M. L., Ritz, C., Astrup, A., & Raben, A. (2016) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.116.134932 · Cited by 66
Effect of atorvastatin on highdensity lipoprotein cholesteroland its relationship withcoronary events: a subgroupanalysis of the GREekAtorvastatin and Coronary-heart-disease Evaluation (GREACE) Study
Athyros, V. G., Mikhailidis, D. P., Papageorgiou, A. A., Symeonidis, A. N., Mercouris, B. R., Pehlivanidis, A. N., Bouloukos, V. I., Elisaf, M., & for the GREACE Study Collaborative Group (2004) · Current Medical Research and Opinion · doi:10.1185/030079904125003421 · Cited by 65
Relationship between total cholesterol/high-density lipoprotein cholesterol ratio, triglyceride/high-density lipoprotein cholesterol ratio, and high-density lipoprotein subclasses
Jia, L., Long, S., Fu, M., Yan, B., Tian, Y., Xu, Y., & Gou, L. (2006) · Metabolism · doi:10.1016/j.metabol.2006.04.004 · Cited by 64
Antidyslipidemic activity of polyprenol from Coccinia grandis in high-fat diet-fed hamster model
Singh, G., Gupta, P., Rawat, P., Puri, A., Bhatia, G., & Maurya, R. (2007) · Phytomedicine · doi:10.1016/j.phymed.2007.06.008 · Cited by 65
Induction of Fatal Inflammation in LDL Receptor and ApoA-I Double-Knockout Mice Fed Dietary Fat and Cholesterol
Zabalawi, M., Bhat, S., Loughlin, T., Thomas, M. J., Alexander, E. T., Cline, M., Bullock, B. C., Willingham, M. C., & Sorci‐Thomas, M. G. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63480-3 · Cited by 65
The impact of vitamin and/or mineral supplementation on lipid profiles in type 2 diabetes
Farvid, M. S., Siassi, F., Jalali, M., Hosseini, M., & Saadat, N. (2004) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2003.11.009 · Cited by 65
Cholesterol profile in people with newly diagnosed coeliac disease: a comparison with the general population and changes following treatment
Lewis, N. R., Sanders, D. S., Logan, R. F., Fleming, K. M., Hubbard, R., & West, J. (2009) · British Journal Of Nutrition · doi:10.1017/s0007114509297248 · Cited by 65
Dietary Total Antioxidant Capacity and Cardiovascular Disease Risk Factors: A Systematic Review of Observational Studies
Mozaffari, H., Daneshzad, E., Surkan, P. J., & Azadbakht, L. (2018) · Journal of the American College of Nutrition · doi:10.1080/07315724.2018.1441079 · Cited by 65
HDL cholesterol and ASCVD risk stratification: A debate
Barter, P. J., & Genest, J. J. (2019) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2019.01.001 · Cited by 68
Effects of atorvastatin on the HDL subpopulation profile of coronary heart disease patients
Asztalos, B. F., Horvath, K. V., McNamara, J. R., Roheim, P. S., Rubinstein, J. J., & Schaefer, E. J. (2002) · Journal of Lipid Research · doi:10.1194/jlr.m200037-jlr200 · Cited by 65
Anacetrapib, a Novel CETP Inhibitor: Pursuing a New Approach to Cardiovascular Risk Reduction
Gutstein, D. E., Krishna, R., Johns, D. G., Surks, H. K., Dansky, H. M., Shah, S., Mitchel, Y., Arena, J. P., & Wagner, J. A. (2011) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2011.271 · Cited by 64
Gender Differences in Atherosclerotic Vascular Disease: From Lipids to Clinical Outcomes
Vakhtangadze, T., Tak, R. S., Singh, U., Baig, M. S., & Bezsonov, E. E. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.707889 · Cited by 66
HDL cholesterol concentrations and risk of atherosclerotic cardiovascular disease – Insights from randomized clinical trials and human genetics
Kjeldsen, E. W., Thomassen, J. Q., & Frikke‐Schmidt, R. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2021.159063 · Cited by 70
Prevalence of Dyslipidaemia and Associated Risk Factors in a Rural Population in South-Western Uganda: A Community Based Survey
Asiki, G., Murphy, G. A. V., Baisley, K. J., Nsubuga, R. N., Karabarinde, A., Newton, R., Seeley, J., Young, E. H., Kamali, A., & Sandhu, M. S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0126166 · Cited by 62
High density lipoprotein cholesterol: an evolving target of therapy in the management of cardiovascular disease
Kapur, N. K. (2008) · Vascular Health and Risk Management · doi:10.2147/vhrm.2008.04.01.39 · Cited by 72
Anionic Phospholipids Lose Their Procoagulant Properties When Incorporated into High Density Lipoproteins
Oslakovic, C., Krisinger, M. J., Andersson, A., Jauhiainen, M., Ehnholm, C., & Dahlbäck, B. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m807286200 · Cited by 66
Twenty-year trends in cardiovascular risk factors in India and influence of educational status
Gupta, R., Guptha, S., Gupta, V., Agrawal, A., Gaur, K., & DEEDWANIA, P. C. (2011) · European Journal of Preventive Cardiology · doi:10.1177/1741826711424567 · Cited by 65
Physical Stability of the Amorphous Anticholesterol Agent (Ezetimibe): The Role of Molecular Mobility
Knapik-Kowalczuk, J., Wojnarowska, Ż., Grzybowska, K., Hawełek, Ł., Sawicki, W., Wlodarski, K., Markowski, J., & Paluch, M. (2014) · Molecular Pharmaceutics · doi:10.1021/mp500498e · Cited by 64
2015 Korean Guidelines for Management of Dyslipidemia
Committee for Guidelines for Management of Dyslipidemia (2015) · Journal of Lipid and Atherosclerosis · doi:10.12997/jla.2015.4.1.61 · Cited by 65
Do elevated levels of abdominal visceral adipose tissue contribute to age-related differences in plasma lipoprotein concentrations in men?
Lemieux, S. (1995) · Atherosclerosis · doi:10.1016/0021-9150(95)05603-t · Cited by 66
African American-White Differences in Lipids, Lipoproteins, and Apolipoproteins, by Educational Attainment, among Middle-aged Adults: The Atherosclerosis Risk in Communities Study
Metcalf, P. A., Sharrett, A. R., Folsom, A. R., Duncan, B. B., Patsch, W., Hutchinson, R. G., Szklo, M., DAVIS, C. E., & Tyroler, H. A. (1998) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009696 · Cited by 64
Self-citation
The inflammation: Lipoprotein cycle
Barter, P. J. (2005) · Atherosclerosis Supplements · doi:10.1016/j.atherosclerosissup.2005.02.004 · Cited by 64
The value of HDL genetics
Holleboom, A. G., Vergeer, M., Hovingh, G. K., Kastelein, J. J. P., & Kuivenhoven, J. A. (2008) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e328306a043 · Cited by 64
Guidelines for the Management of Patients with Chronic Stable Angina: Treatment
Fihn, S. D., Williams, S. V., Daley, J., & Gibbons, R. J. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-135-8_part_1-200110160-00014 · Cited by 64
MR-LDP: a two-sample Mendelian randomization for GWAS summary statistics accounting for linkage disequilibrium and horizontal pleiotropy
Cheng, Q., Yang, Y., Shi, X., Yeung, K.-F., Yang, C., Peng, H., & Liu, J. (2020) · NAR Genomics and Bioinformatics · doi:10.1093/nargab/lqaa028 · Cited by 63
Update on the clinical utility of fenofibrate in mixed dyslipidemias: mechanisms of action and rational prescribing
Farnier, M. (2008) · Vascular Health and Risk Management · doi:10.2147/vhrm.s3390 · Cited by 65
Can dysfunctional HDL explain high coronary artery disease risk in South Asians?
Dodani, S., Kaur, R., Reddy, S. N., Reed, G. L., Navab, M., & George, V. T. (2008) · International Journal of Cardiology · doi:10.1016/j.ijcard.2007.12.019 · Cited by 64
Glycine Dimerization Motif in the N-terminal Transmembrane Domain of the High Density Lipoprotein Receptor SR-BI Required for Normal Receptor Oligomerization and Lipid Transport
Gaidukov, L., Nager, A. R., Xu, S., Penman, M., & Krieger, M. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.229872 · Cited by 63
Quantification of HDL Proteins, Cardiac Events, and Mortality in Patients with Type 2 Diabetes on Hemodialysis
Kopecky, C., Genser, B., Drechsler, C., Krane, V., Kaltenecker, C. C., Hengstschläger, M., März, W., Wanner, C., Säemann, M. D., & Weichhart, T. (2014) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.06560714 · Cited by 63
Evaluation of the safety and tolerability of prolonged-release nicotinic acid in a usual care setting: the NAUTILUS study
Vogt, A., Kassner, U., Hostalek, U., Steinhagen‐Thiessen, E., & on behalf of the NAuTiluS Study Group (2006) · Current Medical Research and Opinion · doi:10.1185/030079906x89766 · Cited by 63
Regulation of High-Density Lipoprotein on Hematopoietic Stem/Progenitor Cells in Atherosclerosis Requires Scavenger Receptor Type BI Expression
Gao, M., Zhao, D., Schouteden, S., Sorci‐Thomas, M. G., Veldhoven, P. P. V., Eggermont, K., Liu, C., Verfaillie, C. M., & Feng, Y. (2014) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.114.304006 · Cited by 67
Progressive Resistance Training in End-Stage Renal Disease: Systematic Review
Chan, D., & Cheema, B. S. (2016) · American Journal of Nephrology · doi:10.1159/000446847 · Cited by 64
Effects of an 8-week weight-loss program on cardiovascular disease risk factors and regional body composition
Volek, J., Gómez, A., Love, D., Weyers, A. M., Hesslink, R. L., Wise, J., & Kraemer, W. J. (2002) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1601362 · Cited by 63
Effects of three months' diet after diagnosis of Type 2 diabetes on plasma lipids and lipoproteins (UKPDS 45)
UK Prospective Diabetes Study (UKPDS) Group, Manley, S. E., STRATTON, I. M., Cull, C. A., Frighi, V., Eeley, E. A., Matthews, D. R., Holman, R. R., Turner, R. C., & Neil, H. A. W. (2000) · Diabetic Medicine · doi:10.1046/j.1464-5491.2000.00320.x · Cited by 60
Lipids and cardiovascular disease: Do the findings and therapy apply equally to men and women?
LaRosa, J. C. (1992) · Women s Health Issues · doi:10.1016/s1049-3867(05)80278-6 · Cited by 63
Effects of high-density lipoprotein targeting treatments on cardiovascular outcomes: A systematic review and meta-analysis
Riaz, H., Khan, S. U., Rahman, H., Shah, N. P., Kaluski, E., Lincoff, A. M., & Nissen, S. E. (2019) · European Journal of Preventive Cardiology · doi:10.1177/2047487318816495 · Cited by 61
New Perspectives on Atherogenic Dyslipidaemia and Cardiovascular Disease
Lorenzatti, A. J., & Toth, P. P. (2020) · European Cardiology Review · doi:10.15420/ecr.2019.06 · Cited by 62
Myeloperoxidase, inflammation, and dysfunctional high-density lipoprotein
Smith, J. D. (2010) · Journal of clinical lipidology · doi:10.1016/j.jacl.2010.08.007 · Cited by 62
Different impact of high-density lipoprotein-related genetic variants on polypoidal choroidal vasculopathy and neovascular age-related macular degeneration in a Chinese Han population
Zhang, X., Li, M., Wen, F., Zuo, C., Chen, H., Wu, K., & Zeng, R. (2012) · Experimental Eye Research · doi:10.1016/j.exer.2012.12.005 · Cited by 62
Atheroprotective lipoprotein effects of a niacin-simvastatin combination compared to low- and high-dose simvastatin monotherapy
Airan‐Javia, S., Wolf, R. L., Wolfe, M. L., Tadesse, M. G., Mohler, E. R., & Reilly, M. P. (2009) · American Heart Journal · doi:10.1016/j.ahj.2009.01.001 · Cited by 62
Diabetic Cardiomyopathy: Impact of Biological Sex on Disease Development and Molecular Signatures
Toedebusch, R. G., Belenchia, A. M., & Pulakat, L. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00453 · Cited by 65
Intensive Lowering of Low-Density Lipoprotein Cholesterol Levels for Primary Prevention of Coronary Artery Disease
Karalis, D. G. (2009) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(11)60544-2 · Cited by 61
The use of ezetimibe in achieving low density lipoprotein lowering goals in clinical practice: position statement of a United Kingdom consensus panel
Mikhailidis, D. P., Wierzbicki, A. S., Daskalopoulou, S. S., Al-Saady, N. M., Griffiths, H. R., Hamilton, G., Monkman, D., Patel, V., Pittard, J., & Schächter, M. (2005) · Current Medical Research and Opinion · doi:10.1185/030079905x48447 · Cited by 62
Epidemiological aspects of high density lipoprotein cholesterol1Presented at the 68th meeting of the European Atherosclerosis Society, Brugge, 8–10 May, 1997.1
Backer, G. D., Bacquer, D. D., & Kornitzer, M. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(97)00310-9 · Cited by 62
Effect of Overexpression of Human Apo A-I in C57BL/6 and C57BL/6 Apo E–Deficient Mice on 2 Lipoprotein-Associated Enzymes, Platelet-Activating Factor Acetylhydrolase and Paraoxonase
Geest, B. D., Stengel, D., Landeloos, M., Lox, M., Gat, L. L., Collen, D., Holvoet, P., & Ninio, E. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.10.e68 · Cited by 62
Fibrates in the prevention of cardiovascular disease in patients with type 2 diabetes mellitus--a pooled meta-analysis of randomized placebo-controlled clinical trials
Saha, S. A., & Arora, R. R. (2010) · International Journal of Cardiology · doi:10.1016/j.ijcard.2008.11.211 · Cited by 61
The effects of menopause on the serum lipid profile of normal females of South East Nigeria.
Igweh, J. C., Nwagha, I. U., & Okaro, J. M. (2005) · PubMed · Cited by 61
New and Emerging Risk Factors for Coronary Heart Disease
Akhabue, E., Thiboutot, J. P., Cheng, J.-W., Lerakis, S., Vittorio, T. J., Christodoulidis, G., Grady, K. M., & Kosmas, C. E. (2013) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e31828aab45 · Cited by 64
Serum High-Density Lipoprotein Cholesterol Levels and Mortality in Frail, Community-Living Elderly
Landi, F., Russo, A., Pahor, M., Capoluongo, E., Liperoti, R., Cesari, M., Bernabei, R., & Onder, G. (2007) · Gerontology · doi:10.1159/000111381 · Cited by 61
Nutritional lipidomics: Molecular metabolism, analytics, and diagnostics
Smilowitz, J. T., Zivkovic, A. M., Wan, Y. Y., Watkins, S. M., Nording, M. L., Hammock, B. D., & German, J. B. (2013) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201200808 · Cited by 62
Cholesterol Acyltransferase Gene Mutations Have Accelerated Atherogenesis as Assessed by Carotid 3.0-T Magnetic Resonance Imaging
Duivenvoorden, R., Holleboom, A. G., van den Bogaard, B., Nederveen, A. J., de Groot, E., Hutten, B. A., Schimmel, A. W. M., Hovingh, G. K., Kastelein, J. J. P., Kuivenhoven, J. A., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.11.092 · Cited by 61
Effect of HDL composition and particle size on the resistance of HDL to the oxidation
Nakanishi, S., Söderlund, S., Jauhiainen, M., & Taskinen, M. (2010) · Lipids in Health and Disease · doi:10.1186/1476-511x-9-104 · Cited by 61
A Comparison of the Effects of Nevirapine and Nelfinavir on Metabolism and Body Habitus in Antiretroviral-Naive Human Immunodeficiency Virus-Infected Patients: A Randomized Controlled Study
Fisac, C., Virgili, N. M., Ferrer, E., Barberà, M. J., Fumero, E., Vilarasau, C., & Podzamczer, D. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021830 · Cited by 61
The Relationship between Very High Levels of Serum High-Density Lipoprotein Cholesterol and Cause-Specific Mortality in a 20-Year Follow-Up Study of Japanese General Population
Hirata, A., Okamura, T., Sugiyama, D., Kuwabara, K., Kadota, A., Fujiyoshi, A., Miura, K., Okuda, N., Ohkubo, T., Okayama, A., et al. (2016) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.33449 · Cited by 61
Polymorphisms of the gene encoding cholesterol ester transfer protein and serum lipoprotein levels in subjects with and without coronary heart disease
Tenkanen, H., Koskinen, P., KONTULA, K. K., Aalto‐Setälä, K., M�ntt�ri, M., Manninen, V., Runeberg, S.-L., Taskinen, M., & Ehnholm, C. (1991) · Human Genetics · doi:10.1007/bf00209015 · Cited by 61
Common polymorphisms of ATP binding cassette transporter A1, including a functional promoter polymorphism, associated with plasma high density lipoprotein cholesterol levels in Turks
Hodoğlugil, U., WILLIAMSON, D., Huang, Y. M., & Mahley, R. W. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.03.004 · Cited by 61

Authors: Gordon, D. J., Probstfield, J. L., Garrison, R. J., Neaton, J. D., Castelli, W. P., Knoke, J. D., Jacobs, D. R., Bangdiwala, S., & Tyroler, H. A.
Affiliations: National Institutes of Health (US)
ORCID: Probstfield, J L
Neaton, J D
Knoke, J D
Jacobs, D R
Bangdiwala, S
Venue: Circulation
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 1989-01
Volume: 79
Issue: 1
Pages: 8-15
ISSN: 0009-7322 (ISSN-L)
1524-4539
DOI: 10.1161/01.cir.79.1.8
OpenAlex: W2077760013
Cited by: 3,162
References: 27
Citations by year: 2026: 35 · 2025: 41 · 2024: 62 · 2023: 69 · 2022: 90 · 2021: 90 · 2020: 90 · 2019: 84 · 2018: 96 · 2017: 87 · 2016: 81 · 2015: 125 · 2014: 137 · 2013: 125 · 2012: 129
FWCI: 61.95
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Circulation (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health (n01hv012156-034)
National Heart, Lung, and Blood Institute (N01-HV32961, N01-HV 12156, N01-HV 12159)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords: HDL cholesterol, coronary artery disease, cardiovascular mortality, inverse association, Framingham Heart Study, Multiple Risk Factor Intervention Trial, British Regional Heart Study, cardiovascular risk, sex differences
MeSH terms: Adult, Aged, Cardiovascular Diseases, Clinical Trials as Topic, Female, Humans, Cholesterol, HDL, Male, Middle Aged, Prospective Studies, Regression Analysis, Risk Factors, Sex Factors, Statistics as Topic, Cohort Studies

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks